Terbinafine Dosing for Scalp Ringworm (Tinea Capitis)
For scalp ringworm caused by Trichophyton species, give oral terbinafine once daily for 2-4 weeks based on body weight: 62.5 mg/day for children <20 kg, 125 mg/day for 20-40 kg, and 250 mg/day for >40 kg. 1
Critical First Step: Identify the Causative Organism
The choice and duration of terbinafine therapy depends entirely on which fungus is causing the infection:
- Trichophyton species (T. tonsurans, T. violaceum, T. soudanense): Terbinafine is highly effective and preferred
- Microsporum species (M. canis, M. audouinii): Terbinafine performs poorly—griseofulvin is superior 1
If you don't know the organism yet, it's reasonable to start treatment empirically while awaiting culture results if cardinal signs are present (scale, lymphadenopathy, alopecia) 1. Consider local epidemiology—in North America, T. tonsurans predominates, making terbinafine an excellent first choice 2.
Weight-Based Dosing Schedule
Give terbinafine once daily at these doses 1:
- <20 kg: 62.5 mg per day
- 20-40 kg: 125 mg per day
- >40 kg: 250 mg per day
Treatment Duration
Standard duration: 2-4 weeks 1
The evidence shows that:
- 2 weeks is optimal for Trichophyton infections when balancing efficacy, cost, and compliance 3
- 4 weeks may be needed for more severe cases or treatment failures 1
- 1 week is insufficient—cure rates drop significantly 3, 4
Research directly comparing durations found that 2-week and 4-week regimens achieved similar mycological cure rates (76% vs 72%), both significantly better than 1-week treatment (60%) 3.
Key Advantages of Terbinafine
- Shorter treatment course than griseofulvin (2-4 weeks vs 6-8 weeks), improving compliance 1
- Fungicidal rather than fungistatic 1
- Superior efficacy against Trichophyton species—complete cure rates of 45% vs 39% for griseofulvin in large trials 2
Critical Limitation: Microsporum Species
Terbinafine fails against Microsporum canis. The drug cannot reach adequate concentrations in hair and doesn't get excreted in sweat/sebum of prepubertal children, so it can't reach the scalp surface where Microsporum arthroconidia reside 1. For M. canis, griseofulvin achieves significantly better cure rates 2, 5.
Even high doses (6-12.5 mg/kg/day for 8 weeks) are needed for M. canis, with cure rates of 91-100% at these higher doses 5. However, this is not the standard recommendation—switch to griseofulvin instead 1.
Managing Treatment Failure
If there's no clinical improvement after the initial course 1:
- First, consider non-compliance, poor drug absorption, or reinfection
- If there's clinical improvement but positive mycology persists, continue current therapy for another 2-4 weeks
- If no initial improvement, switch to second-line therapy (itraconazole for Trichophyton, griseofulvin for Microsporum)
Safety Considerations
Terbinafine is well-tolerated in children with adverse events in <8% (mostly mild GI upset and rash), and only 0.8% require discontinuation 1, 2. However, the FDA label warns about rare but serious hepatotoxicity, taste/smell disturbances, and severe skin reactions 6. While baseline liver function tests are recommended in adults, the British guidelines don't mandate this for short-course pediatric treatment.
Important Caveats
- Oral therapy is mandatory—topical treatment alone is inadequate 1
- Terbinafine is not licensed for tinea capitis in children in the UK, though widely used based on extensive evidence 1
- Screen and treat household contacts for T. tonsurans cases to prevent reinfection 1
- The endpoint is mycological cure (negative culture), not just clinical improvement 1